Evidence map›Paper›PMID 42016221›Full record

ReviewERJ open research2026

Beyond spirometry: understanding COPD origins to support a new diagnostic approach.

Tommaso Morelli, Madison E Geeves, Ahmed Mohammed, Cosma Mirella Spalluto, Jodie Ackland, Anna Freeman, Farhan Ullah, Jake Weeks, Lee Page, Alex Kong and 7 more

Abstract readReview
In one paragraph

Review in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Definitions of early COPD and predictors for disease progression: a systematic review.European respiratory review : an official journal of the European Respiratory Society · 2026
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Tommaso MorelliFaculty of Medicine, University of Southampton, Southampton, UK.
Madison E GeevesFaculty of Medicine, University of Southampton, Southampton, UK.
Ahmed MohammedFaculty of Medicine, University of Southampton, Southampton, UK.
Cosma Mirella SpallutoFaculty of Medicine, University of Southampton, Southampton, UK.ORCID https://orcid.org/0000-0001-7273-0844
Jodie AcklandFaculty of Medicine, University of Southampton, Southampton, UK.ORCID https://orcid.org/0000-0003-3120-3620
Anna FreemanFaculty of Medicine, University of Southampton, Southampton, UK.
Farhan UllahFaculty of Medicine, University of Southampton, Southampton, UK.
Jake WeeksFaculty of Medicine, University of Southampton, Southampton, UK.
Lee PageFaculty of Medicine, University of Southampton, Southampton, UK.
Alex KongFaculty of Medicine, University of Southampton, Southampton, UK.
Benjamin WelhamFaculty of Medicine, University of Southampton, Southampton, UK.ORCID https://orcid.org/0000-0001-9683-252X
Arda TarcanFaculty of Medicine, University of Southampton, Southampton, UK.ORCID https://orcid.org/0009-0003-0937-6995
Martha PurcellFaculty of Medicine, University of Southampton, Southampton, UK.ORCID https://orcid.org/0000-0002-9913-9971
Claire SimmsFaculty of Medicine, University of Southampton, Southampton, UK.
Karl J StaplesFaculty of Medicine, University of Southampton, Southampton, UK.ORCID https://orcid.org/0000-0003-3844-6457
Alastair WatsonFaculty of Medicine, University of Southampton, Southampton, UK.ORCID https://orcid.org/0000-0002-6735-2567
Tom Ma WilkinsonFaculty of Medicine, University of Southampton, Southampton, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COPD remains a leading cause of morbidity and mortality, with outcomes stagnating relative to other long-term conditions. Current diagnostic pathways rely on spirometry, which detects airflow obstruction only after irreversible small airway and parenchymal damage has accrued, whereas pathogenic processes begin decades earlier. This review examines how understanding early pathogenic processes could inform alternative approaches to diagnosis and treatment. We highlight the contribution of developmental and environmental exposures, genetic susceptibility and epigenetic modification to disease initiation. We outline how these convergent mechanisms drive structural and functional abnormalities undetectable by conventional diagnostics but measurable with novel techniques. Advanced imaging-parametric response mapping, hyperpolarised gas magnetic resonance imaging and computed tomography-based vascular metrics-can detect emphysema, small airways disease and vascular pruning before spirometric thresholds are reached. Physiological tools including forced oscillation techniques and capnography show promise for early detection in primary care and may be scalable, affordable alternatives to spirometry. Biofluid-based platforms, including exhaled breath analysis, extracellular matrix neo-epitopes and blood-based inflammatory signatures, offer noninvasive phenotyping and risk stratification, though require validation and pathway integration. We argue for a shift from a spirometry-centric model to a multidimensional diagnostic framework integrating imaging, molecular, physiological and biomarker data. Recent longitudinal evidence, including diagnostic schemas combining imaging with symptom burden, indicates that such approaches identify high-risk individuals missed by spirometry alone. Proactive COPD detection in its earliest stages is therefore an essential step to altering disease trajectory and improving patient outcomes, and it is time our community looks beyond spirometry to deliver this.

Identifiers

PMID42016221
PMCPMC13093653

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.